Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Aurobindo Pharma receives USFDA Approval for Saxagliptin Tablets, 2.5 mg and 5 mg.".
Press Release Aug 01 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Jul 25 2023
- Press Release Jul 12 2023
- Press Release Jul 04 2023
- Press Release Jun 23 2023
- Press Release May 27 2023
Later from Aurobindo Pharma
- Aurobindo Pharma Ltd Press Release Aug 07 2023
- Annual CSR Report 2022-23
- Press Release Aug 12 2023
- Q1 – UFR 2023-24
- Earnings Presentation-Q1 FY 2023-24
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma